Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: Results of the TIMI 31 trial

By Gibson C.   Zorkun Cafer   Molhoek Peter   Żmudka Krzysztof   Greenberg Mark   Mueller Hiltrud   Wesdorp Jan   Louwerenburg Hans   Niederman Alan   Westenburg Jaap   Bikkina Mahesh   Batty John   Winter Jobst   Murphy Sabina   McCabe Carolyn  

Journal of Thrombosis and Thrombolysis, Vol. 22, Iss. 1, 2006-08 ,pp. : 13-21

Springer Publishing Company

Access to resources Recommend Favorite

Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study

By Petersenn Stephan   Farrall Andrew   Block Christophe   Melmed Shlomo   Schopohl Jochen   Caron Philippe   Cuneo Ross   Kleinberg David   Colao Annamaria   Ruffin Matthieu   Hermosillo Reséndiz Karina   Hughes Gareth   Hu Ke   Barkan Ariel  

Pituitary, Vol. 17, Iss. 2, 2014-04 ,pp. : 132-140

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Usefulness of Somatostatin Receptor Scintigraphy in Japanese Patients with Gastroenteropancreatic Neuroendocrine Tumors

By  

Digestion, Vol. 96, Iss. 1, 2017-06 ,pp. : 13-20

Karger

Access to resources Recommend Favorite

Comparison of efficacy and tolerability of somatostatin analogs and other therapies for acromegaly

By Burt Morton   Ho Ken  

Endocrine Journal, Vol. 20, Iss. 3, 2003-04 ,pp. : 299-305

Humana Press, Inc

Access to resources Recommend Favorite

Efficacy and safety of single-dose mizoribine for patients with rheumatoid arthritis: results at 6 months after switching from a multiple-dose regimen without a change in total daily dose

By Nishimura Keita  

Modern Rheumatology, Vol. 21, Iss. 2, 2011-04 ,pp. : 158-163

Springer Publishing Company

Access to resources Recommend Favorite